• CEPHEID Analyst Recommendations

  • Analyst Consensus: CPHD

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.111 Buy 9
    30 Days Ago 2.000 Buy 9
    60 Days Ago 1.667 Buy 9
    90 Days Ago 1.625 Buy 8
    120 Days Ago 1.625 Buy 8

  • Analyst Ratings: CPHD

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Piper Jaffray Buy Neutral 09/10/2008 —
    UBS Buy Neutral 08/14/2008 23.00
    UBS — Buy 07/28/2008 23.00
    Caris & Company — Buy 07/25/2008 27.00
    RBC Capital Mkts Outperform Underperform 07/25/2008 —
    RBC Capital Mkts — Outperform 07/15/2008 34.00
    UBS Neutral Buy 04/17/2008 —
    Caris & Company Above Average Buy 03/11/2008 34.00
    Caris & Company — Above Average 02/29/2008 34.00
    Piper Jaffray Neutral Buy 11/28/2007 —
    Caris & Company — Above Average 11/02/2007 30.00
    Piper Jaffray — Market Perform 10/11/2007 —
    Caris & Company — Above Average 10/03/2007 25.00
    UBS Buy Neutral 09/05/2007 —
    First Analysis Sec — Equal-Weight 08/28/2007 —
    Caris & Company Buy Above Average 08/23/2007 21.00
    UBS — Buy 08/08/2007 19.00
    UBS — Buy 07/05/2007 18.00
    Caris & Company Above Average Buy 06/13/2007 —
    William Blair — Outperform 06/12/2007 —
    Thomas Weisel — Overweight 04/09/2007 13.50
    Thomas Weisel — Overweight 03/20/2007 12.00
    UBS — Neutral 02/23/2007 10.50
    UBS — Neutral 11/03/2006 9.50
    UBS Buy Neutral 09/26/2006 9.00
    UBS — Buy 08/09/2006 10.50
    Caris & Company — Above Average 03/29/2006 —
    Robert W. Baird — Outperform 03/21/2006 13.00
    UBS Neutral Buy 01/05/2006 12.50
    UBS — Neutral 11/29/2005 13.00
    Next